Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired immunodeficiency syndrome.

K V Rolston1, G P Bodey

  • 1Department of Internal Medicine, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.

Seminars in Surgical Oncology
|January 1, 1986
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1992
Same author

Infectious complications of indwelling vascular catheters.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1992
Same author

Viral pneumonia in the immunocompromised adult with neoplastic disease: the role of common community respiratory viruses.

Seminars in respiratory infections·1992
Same author

Lack of activity of amphotericin B in systemic murine fusarial infection.

The Journal of infectious diseases·1992
Same author

Evaluation of strategies for central venous catheter replacement.

Critical care medicine·1992
Same author

Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1992
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Acquired immunodeficiency syndrome (AIDS) is a severe condition caused by the human T-lymphotropic virus/lymphadenopathy associated virus (HTLV-III/LAV). Current research focuses on antiviral therapies, immune restoration, and vaccine development, as no cure exists.

Area of Science:

  • Immunology
  • Virology
  • Epidemiology

Background:

  • Acquired immunodeficiency syndrome (AIDS) emerged in 1981, marked by opportunistic infections and Kaposi's sarcoma.
  • High-risk populations include homosexual men, intravenous drug users, hemophiliacs, and recipients of blood products.
  • AIDS is linked to immunologic deficits such as lymphopenia and T-cell dysfunction.

Purpose of the Study:

  • To define Acquired Immunodeficiency Syndrome (AIDS) as a distinct clinical entity.
  • To identify the causative agent and spectrum of disease associated with HTLV-III/LAV infection.
  • To outline current research directions for managing AIDS.

Main Methods:

  • Clinical observation and characterization of opportunistic infections and Kaposi's sarcoma.

Related Experiment Videos

  • Identification of immunologic abnormalities in affected individuals.
  • Virologic identification of the Human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV).

    • Main Results:

    • AIDS is characterized by severe immune compromise and opportunistic infections.
    • The Human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) is identified as the causative agent.
    • AIDS represents the most severe manifestation of HTLV-III/LAV infection, with a spectrum including asymptomatic carriage and AIDS-related complex (ARC).

    Conclusions:

    • No effective therapy for AIDS is currently available.
    • Global research is focused on developing antiviral treatments, immune-restoring therapies, and a preventative vaccine.
    • AIDS is a worldwide health concern requiring urgent scientific intervention.